Profile
Dr. Deng Weifen, Director of the Department of Reproductive Medicine at Shenzhen Hengsheng Hospital, possesses over 20 years of professional expertise and management experience in reproductive medicine. Under her leadership, her clinical team has successfully completed more than 40,000 IVF cycles, helping tens of thousands of families realize their dreams of parenthood. As a collaborating principal investigator, she has presided over one project funded by the National Natural Science Foundation of China and completed several municipal-level research projects. She has published one SCI article and over 60 papers in national and core journals. In 2015, she undertook exchange studies at the Stanford University Reproductive Center.
Positions
· Chairman, Integrated Traditional Chinese and Western Medicine Reproductive Health Committee, Shenzhen Non-Government Medical Institutions Association
· Committee Member, Reproductive Medicine and Reproductive Ethics Committee, China Scientific Association for Better Birth and Childcare
· Committee Member, Reproductive Immunology Professional Committee, National Maternal and Child Health Research Association
· Standing Committee Member, Infertility Professional Committee, Cross-Strait Medicine and Health Exchange Association
· Committee Member, Reproductive Medicine Branch, Guangdong Medical Association
Speciality
1. Professional technology and management in reproductive medicine.
2. Research on repeated IVF failure.
3. Recurrent spontaneous abortion and precise miscarriage prevention.
4. Conservative treatment of chocolate cysts (endometriomas) and achieving high pregnancy rates.
5. Menstrual disorders (including Polycystic Ovary Syndrome, etc.).
6. Research on integrated Traditional Chinese and Western Medicine strategies to improve pregnancy rates in cases of abnormal endometrium (including intrauterine adhesions, thin endometrium, scar diverticulum, etc.).
7. Management of Polycystic Ovary Syndrome (PCOS), advanced maternal age, and diminished ovarian reserve.
A patient who successfully conceived after receiving treatment from Dr. Deng Weifen presents a banner to Director Deng Weifen.
"When infertility affects a family, women often bear greater pressure," Director Deng Weifen stated. In 2001, she entered the field of assisted reproduction and began studying IVF technology. At the time, IVF was an emerging technology. During her training at the Reproductive Center of the First Affiliated Hospital of Sun Yat-sen University, she had the privilege of meeting Professor Zhuang Guanglun, renowned as the "Father of Test-Tube Babies" in China and the inaugural President of the Global Chinese Society of Reproductive Medicine. Professor Zhuang became her mentor in assisted reproduction, providing frequent technical guidance, mentoring her through complex procedures, and involving her in discussions on challenging cases, sharing new knowledge and technologies in the field. Director Deng expresses profound gratitude for her mentor's guidance.
Professor Zhuang Guanglun and Director Deng Weifen delivering a lecture together.
In 2015, Director Deng pursued further studies at the Stanford University Reproductive Center in the United States. During this period, she seized every learning opportunity, gaining knowledge not only of cutting-edge international reproductive technologies but also insights into the patient-centered service model in the US, which broadened her perspective for the future operational management of reproductive medicine departments.
Ovarian endometriomas (chocolate cysts) and abnormal endometrium are common causes of female infertility. Abnormal endometrium includes thin endometrium, thick endometrium, and intrauterine fluid, which severely impact embryo implantation. Infections during pregnancy can lead to miscarriage, premature rupture of membranes, and stillbirth. Current treatments for abnormal endometrium vary, and establishing a consistently effective diagnostic and therapeutic protocol remains a key research focus in reproductive medicine. Since 2013, under the guidance of Professor Sun Wei (a recipient of the State Council Special Allowance) and Professor Wang Aiming (former Director of the Department of Obstetrics and Gynecology and Reproductive Center at the former Navy General Hospital, and doctoral supervisor), Director Deng's team has dedicated efforts to research. Through nearly a decade of clinical practice, they have gradually developed an effective integrated Traditional Chinese and Western Medicine approach for treating abnormal endometrium.
In 2020, she established the Integrated Traditional Chinese and Western Medicine Clinic for Abnormal Endometrium at Hengsheng Hospital. This initiative focuses on developing hysteroscopic cold knife techniques that maximize the protection of endometrial reproductive function, along with optimized perioperative management. Concurrently, it employs integrated TCM and Western medicine methods for endometrial management to enhance the pregnancy potential for patients with abnormal endometrium.
Director Deng Weifen established the Integrated Traditional Chinese and Western Medicine Clinic for Abnormal Endometrium.
In her over twenty years dedicated to the field of reproductive medicine, Director Deng has led her team in conducting in-depth research on repeated IVF failure, recurrent pregnancy loss with precise miscarriage prevention, and conservative treatment of endometriomas. She has presided over one National Natural Science Foundation project, completed several municipal-level research projects, published 4 SCI articles, and over 60 papers in national and core journals. She has been frequently invited to participate in academic exchanges in the United States, Europe, Australia, Canada, and other countries, and to lecture and present papers at major domestic reproductive forums.
Director Deng Weifen serving as Chairman of the Integrated Traditional Chinese and Western Medicine Reproductive Health Committee, Shenzhen Non-Government Medical Institutions Association.
Director Deng Weifen consulting with a patient.
Since joining Shenzhen Hengsheng Hospital in 2020 as the Lead Specialist of the Department of Reproductive Medicine, Director Deng has spearheaded significant transformations within the department. While continuously driving innovation, she has vigorously developed reproductive TCM and reproductive andrology services. She has established specialized outpatient services including Genetic and Embryo Counseling, Integrated TCM-Western Medicine for Abnormal Endometrium, Mild Stimulation Cycles, Reproductive Hysteroscopy, Weight Management, Psychological Counseling, Remote Consultations, and Special & VIP Clinics. Furthermore, she has introduced a series of specialized and advanced technologies such as donor sperm IVF, precise miscarriage prevention for recurrent pregnancy loss, minimal residual sperm freezing, anhydrous alcohol solidification for ovarian endometriomas, non-surgical integrated TCM-Western Medicine treatment for uterine scar diverticula, egg activation, and In Vitro Maturation (IVM). These initiatives provide a superior diagnostic and treatment system for infertility patients, especially those with complex conditions. Currently, Hengsheng Hospital's key technical indicators surpass the national average.
Director Deng Weifen organizing and presiding over a difficult case discussion.
Director Deng Weifen leading the establishment of the "Infertility Medical Consortium."
On the afternoon of April 25, 2025, our hospital held a signing and unveiling ceremony for the "Reproductive Health and Infertility Specialty Medical Alliance" between Yuancheng District People's Hospital and Shenzhen Hengsheng Hospital in the fifth-floor conference room, marking a new developmental opportunity for our hospital in the field of reproductive health.
Deng Weifen, Assistant to the President of Shenzhen Hengsheng Hospital and Director of the Reproductive Medicine Department, delivered a presentation titled "Development of the Department of Reproductive Medicine and Its Characteristic Technologies.
